Biomics Biopharma (ASX:BBM) Ending Cash Position: A$0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biomics Biopharma Ending Cash Position?

Biomics Biopharma ASX:BBM Ending Cash Position is A$0.00 Mil as of . 20.

Biomics Biopharma's Ending Cash Position for the quarter that ended in . 20 was A$0.00 Mil.

Biomics Biopharma Ending Cash Position Related Terms

Biomics Biopharma Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Ending Cash Position Chart

Biomics Biopharma Annual Data
Trend
Ending Cash Position

Biomics Biopharma Semi-Annual Data
Ending Cash Position

Biomics Biopharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biomics Biopharma's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Biomics Biopharma's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Ending Cash Position of A$0.00 Mil as of . 20. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Biomics Biopharma and its competitors.
Is Biomics Biopharma's Ending Cash Position too high?
Biomics Biopharma's current Ending Cash Position is A$0.00 Mil.
How does Biomics Biopharma's Ending Cash Position compare to competitors?
Biomics Biopharma's Ending Cash Position of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Biomics Biopharma and its competitors. Biomics Biopharma's current Ending Cash Position is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Ending Cash Position of A$0.00 Mil. The current Ending Cash Position is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Ending Cash Position is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.